iHuman
7 hedge funds and large institutions have $3.44M invested in iHuman in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
75% more funds holding
Funds holding: 4 → 7 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.12% less ownership
Funds ownership: 4.96% → 3.84% (-1.1%)
57% less capital invested
Capital invested by funds: $8.03M → $3.44M (-$4.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$49.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$44K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.9K |
| 4 |
State Street
Boston,
Massachusetts
|
+$638 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APA
Arisaig Partners (Asia)
Singapore
|
-$1.49M |
IH Hedge Fund Activity: Q1 2024 in Review
7 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2024, worth a combined $3.44M — down 57% from $8.03M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IH positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $49.2K. The largest seller was Arisaig Partners (Asia), cutting an estimated $1.49M.
- 7 institutional investors held iHuman (IH) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $3.44M of iHuman stock for Q1 2024, down 57% quarter-over-quarter.
- 3 funds opened new iHuman positions in Q1 2024 and 0 closed out, a net change of +3 holders.
- The largest iHuman buyer in Q1 2024 was Morgan Stanley, an estimated $49.2K added.
- The largest iHuman seller in Q1 2024 was Arisaig Partners (Asia), an estimated $1.49M sold.
Based on aggregated 13F filings for Q1 2024.